WeVote
Log In

Bill

Bill

HB 606

TAX/SALES-USE, LOCAL-EXEM: Exempts prescription drugs and insulin from local sales and use taxes (EG DECREASE LF RV See Note)

2025 Regular Session Introduced by Chris Turner

Louisiana HB 606 removes local sales and use taxes from prescription drugs and insulin to reduce medication costs for patients.

Read by title, returned to the calendar.
0
WeVote Research Nonpartisan
Bill Summary · HB 606

Legislative bill overview

HB 606 exempts prescription drugs and insulin from local sales and use taxes in Louisiana. This means these medications would no longer be subject to local tax rates, though state-level taxation status is not addressed in this bill's scope.

Why is this important

Prescription medications and insulin are essential healthcare products with significant ongoing costs for many households. Removing local tax burdens on these items could reduce out-of-pocket expenses for patients, particularly those managing chronic conditions like diabetes, though the fiscal impact on local governments' revenue would need to be offset elsewhere.

Potential points of contention

  • Local revenue loss: Cities and parishes depend on sales tax revenue for services; this exemption reduces their funding without identified replacement revenue sources
  • Scope limitations: The bill only addresses local taxes, leaving state sales tax on these items intact, which may limit its intended relief effect
  • Implementation complexity: Different local tax rates across Louisiana create administrative challenges for retailers to accurately apply exemptions
  • Equity concerns: Debate over whether this tax relief is the most efficient way to help low-income patients compared to direct assistance programs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.